Search

Displaying results 6301 - 6310 of 8195 in total
  1. Drug

    SJG-136

    go.drugbank.com/drugs/DB11965
    Investigational

    SJG-136 has been used in trials studying the treatment of Recurrent Fallopian Tube Cancer, Secondary Acute Myeloid Leukemia, de Novo Myelodysplastic Syndromes, Recurrent Ovarian Epithelial Cancer, and

    Categories: P-glycoprotein substrates
  2. Drug

    Ribuvaptan

    go.drugbank.com/drugs/DB20059
    Experimental

    Ribuvaptan has a monoisotopic molecular weight of 595.11 Da.

  3. Drug

    Fasobegron

    go.drugbank.com/drugs/DB20200
    Experimental

    Fasobegron has a monoisotopic molecular weight of 425.14 Da.

  4. Drug

    Ruclosporin

    go.drugbank.com/drugs/DB21199
    Experimental

    Ruclosporin has a monoisotopic molecular weight of 1330.92 Da.

  5. Drug

    Filapixant

    go.drugbank.com/drugs/DB21467
    Experimental

    Filapixant has a monoisotopic molecular weight of 521.17 Da.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 Substrates
  6. Drug

    Teplinovivint

    go.drugbank.com/drugs/DB21475
    Experimental

    Teplinovivint has a monoisotopic molecular weight of 442.21 Da.

  7. Drug

    Ipivivint

    go.drugbank.com/drugs/DB21479
    Experimental

    Ipivivint has a monoisotopic molecular weight of 464.19 Da.

  8. Drug

    Vornorexant

    go.drugbank.com/drugs/DB21483
    Experimental

    Vornorexant has a monoisotopic molecular weight of 447.18 Da.

  9. Drug

    Enuvaptan

    go.drugbank.com/drugs/DB21492
    Experimental

    Enuvaptan has a monoisotopic molecular weight of 576.09 Da.

  10. Drug

    Zalospirone

    go.drugbank.com/drugs/DB19481
    Experimental

    Zalospirone has a monoisotopic molecular weight of 419.23 Da.